ALENA COSTULAS: Open Payments
NPI 1851008460 · YUKON, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,709 in 105 payments from 19 companies in 2025. Trend: 2023 $1,410 · 2024 $1,574 · 2025 $1,709
Food & beverage: $1,709
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $250 |
| PFIZER INC. | 16 | $226 |
| ABBVIE INC. | 19 | $223 |
| Lilly USA, LLC | 15 | $222 |
| GlaxoSmithKline, LLC. | 18 | $178 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $144 |
| Abbott Laboratories | 5 | $98 |
| Astellas Pharma US Inc | 4 | $62 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Novo Nordisk Inc | 3 | $45 |
Products named: FARXIGA, MOUNJARO, JARDIANCE, TRELEGY ELLIPTA, PREVNAR 20, VRAYLAR, FREESTYLE LIBRE 3, NURTEC ODT.
Industry payments across OK — which companies pay providers there.
